20 nov
|
Alexion, Astra Zeneca Rare Disease
|
Barcelona
20 nov
Alexion, Astra Zeneca Rare Disease
Barcelona
Lead global market access, pricing, and reimbursement strategy for rare hematological diseases, focusing on PNH and HSCT-TMA indications. Requires deep expertise in integral payer environments and a track record in rare disease commercialization.
📌 Global Pricing (Barcelona)
🏢 Alexion, Astra Zeneca Rare Disease
📍 Barcelona